Dr Michelle Sullivan Neuroendocrine Cancer New Zealand New Zealand

Dr Michelle Sullivan is the part-time CEO of Neuroendocrine Cancer New Zealand, where her focus is increasing awareness of neuroendocrine cancers and advocating for better access to treatments. Michelle is also General Manager of the Cancer Research Trust NZ and a Trustee of the Malaghan Institute for Medical Research. Michelle holds a PhD in protein biochemistry from Massey University and an Honours degree in Biochemistry from the University of Otago.